| Acquired by | Anika Therapeutics |
| Price | $17.1M |
| Date | 12/09 |
| Terms | Cash and Stock |
| Website | fidiapharma.com |
| Category | BioTech |
| Phone | (+39) 049 8232523 |
| info.fab@fidiapha... | |
| Employees | |
| Founded | 1992 |
Fidia Advanced Biopolymers s.r.l. (FAB), Fidia’s subsidiary, was formed in 1992. It is an independent company operating in the advanced biomedical field.
The company utilizes its integrated R&D capabilities to develop devices of novel conception, which are designed to offer advanced solutions to specific clinical needs.
FAB research has produced HYAFF, hyaluronic acid in solid form, a totally biocompatible and biodegradable biomaterial, forerunner of a vast series of biopolymers used in diverse applications, the most sophisticated of which is Tissue Engineering.
